KSE
Search
- Page Path
- HOME > Search
Brief Communication
- Epidemiological evidences on overdiagnosis of prostate and kidney cancers in Korean
- Jong-Myon Bae
- Epidemiol Health. 2015;37:e2015015. Published online March 7, 2015
- DOI: https://doi.org/10.4178/epih/e2015015
- 19,067 View
- 164 Download
- 7 Web of Science
- 10 Crossref
-
Abstract
Summary
PDF
Supplementary Material -
AbstractOBJECTIVES
The prostate specific antigen test is widely used as the main method of screening prostate cancer in Korea. Additionally, the use of ultrasound sonography may lead to overdiagnosis of kidney cancer as well as thyroid cancer. This study aimed to highlight epidemiological evidences regarding overdiagnosis of prostate and kidney cancers in Korean.METHODSThe annual trends of national incidence and mortality of prostate and kidney cancers provided by the Korean Statistical Information Service were evaluated.RESULTSThe rate of increase in the incidence of prostate and kidney cancer was 6 and 5 times higher than that of mortality between 2000 and 2011, respectively. Additionally, the age group showing the highest incidence in prostate cancer shifted from 85 years and older to 75-79 years.CONCLUSIONSThis evidence suggests that prostate and kidney cancers are overdiagnosed in Korea. Further research in this area, using national cancer registry databases, should be encouraged to prevent overdiagnosis. -
SummaryKorean summary
갑상선암의 과진단은 목초음파검사의 시행에 따른 것이란 주장에 따라, 전립선암과 신장암은 각각 전립선특이항원검사와 복부초음파검사의 시행에 따라 과진단이 있을 것으로 예상된다. 과진단의 여부는 검사 시행 이후 발생률이 증가하는 반면, 사망률은 변동이 없는 것으로 판단할 수 있다. 통계청의 해당 암 발생률과 사망률 추이를 살펴볼 때, 국내에서도 전립선암과 신장암에서 과진단이 있음을 확인할 수 있었다. -
Citations
Citations to this article as recorded by
- Twenty-two-year incidence trend of urological cancers in the Republic of Korea: 1999–2020
Seunghyeon Cho, Won-Ju Park
Investigative and Clinical Urology.2024; 65(1): 23. CrossRef - What is the relationship between the local population change and cancer incidence in patients with dyslipidemia: Evidence of the impact of local extinction in Korea
Wonjeong Jeong, Dong‐Woo Choi, Woorim Kim, Kyu‐Tae Han
Cancer Medicine.2024;[Epub] CrossRef - A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up
Sang Hun Song, Jung Kwon Kim, Hakmin Lee, Sangchul Lee, Sung Kyu Hong, Seok-Soo Byun
Investigative and Clinical Urology.2021; 62(1): 32. CrossRef - Risk of thyroid as a first or second primary cancer. A population‐based study in Italy, 1998–2012
Emanuele Crocetti, Veronica Mattioli, Carlotta Buzzoni, Silvia Franceschi, Diego Serraino, Salvatore Vaccarella, Stefano Ferretti, Susanna Busco, Ugo Fedeli, Massimo Varvarà, Fabio Falcini, Manuel Zorzi, Giuliano Carrozzi, Walter Mazzucco, Cinzia Gasparot
Cancer Medicine.2021; 10(19): 6855. CrossRef - Cancer Incidence by Occupation in Korea: Longitudinal Analysis of a Nationwide Cohort
Hye-Eun Lee, Masayoshi Zaitsu, Eun-A Kim, Ichiro Kawachi
Safety and Health at Work.2020; 11(1): 41. CrossRef - The Overdiagnosis of Kidney Cancer in Koreans and the Active Surveillance on Small Renal Mass
Byung Hoon Chi, In Ho Chang
The Korean Journal of Urological Oncology.2018; 16(1): 15. CrossRef - Potential Epigenetic Biomarkers for Prostate Cancer Screening
Jong-Myon Bae
International Neurourology Journal.2018; 22(2): 142. CrossRef - Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea
Jong-Myon Bae
Journal of Preventive Medicine and Public Health.2017; 50(4): 217. CrossRef - It needs adaptation to the 2015 Korean guideline for breast cancer screening
Jong-Myon Bae
Journal of the Korean Medical Association.2015; 58(9): 833. CrossRef - Two different views of interpreting the related evidences on the reply to reader's letter
Jong-Myon Bae
Journal of the Korean Medical Association.2015; 58(12): 1196. CrossRef
- Twenty-two-year incidence trend of urological cancers in the Republic of Korea: 1999–2020
First
Prev
